arrow
A

Alejandro Recio-Mayoral

hospital universitario virgen macarena
H指数:18
被引数:1,894

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Pronóstico a 1 año en pacientes con insuficiencia cardíaca y enfermedad renal crónica: diferencias en relación con el tipo de insuficiencia cardíaca y la gravedad de la insuficiencia renal

1年预测在心力衰竭和慢性肾病患者中的预后:与心力衰竭类型和肾功能衰竭严重程度相关的差异

2026-10-090
PRE
Lipid control in a cohort of patients with cardiorenal disease (LIPID-REN): a subanalysis of the CARDIOREN registry

脂质控制在心肾疾病患者队列中的研究(LIPID-REN):CARDIOREN注册研究的亚组分析

2026-01-010
OAAI
Differences in clinical features and 1-year outcomes of patients with heart failure and reduced, mildly reduced, and preserved ejection fraction in a contemporary cohort: is the clinical profile changing?
2025-03-010
PRE
Clinical utility and safety of finerenone in patients with heart failure: Rationale and design of FINE registry

finerenone在心力衰竭患者中的临床实用性和安全性: 精细注册的原理和设计

2025-02-010
OAAI
Congestion as a crucial factor determining albuminuria in patients with cardiorenal disease
2024-05-150
OAAI
Prevalence and clinical profile of kidney disease in patients with chronic heart failure. Insights from the Spanish cardiorenal registry

慢性心力衰竭患者肾脏疾病的患病率和临床特征。来自西班牙心肾登记处的见解

2024-01-019
PRE
Changes in circulating ApoJ-Glyc levels in patients with suspected acute coronary syndrome: The EDICA trial
2023-11-012
PRE
Sex differences in Cardiorenal Syndrome: Insights from CARDIOREN Registry

心肾综合征的性别差异: 来自CARDIOREN注册表的见解

2023-05-246
PRE
The Role of Frailty in Acute Coronary Syndromes in the Elderly
2018-06-0132
PREAI
Repetitive use of levosimendan in advanced heart failure: need for stronger evidence in a field in dire need of a useful therapy
2017-09-0122
OAAI
Frailty predicts major bleeding within 30 days in elderly patients with Acute Coronary Syndrome
2016-11-0162
PREAI
The role of levosimendan in acute heart failure complicating acute coronary syndrome: A review and expert consensus opinion
2016-09-0165
OAAI